Malaysia vs Oman: The number of people with susceptibility test result for rifampicin
Malaysia
84.34
in 2021
Oman
84.21
in 2021
Malaysia rank
86th
Oman rank
87th
The number of people with susceptibility test result for rifampicin over time
- Malaysia
- Oman
How they compare
Malaysia currently reports 84.34 against 84.21 in Oman, a difference of 0.13.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Oman ahead.
Malaysia ranks 86th and Oman ranks 87th of 146 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malaysia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.05 | 100 | 21.95 | Oman |
| 2020s | 81.15 | 87.9 | 6.75 | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malaysia or Oman?
- Malaysia, at 84.34 against 84.21 in Oman as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malaysia and Oman?
- 0.13, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Oman?
- 5 years are reported by both, from 2017 to 2021.
- How do Malaysia and Oman rank globally for the number of people with susceptibility test result for rifampicin?
- Malaysia ranks 86th and Oman ranks 87th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.